Norway · Series D startup

Who invested in OptiNose

4 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$151Mraised across 4 rounds since 2010, from 4 sources

$49MSeries C$35MSeries C$30MSeries D$37MSeries D
Latest round
Series D, $37MMay 2017
Biggest round
$49MSeries C · Jun 2010
Step-upi
1.2×
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20102011201220132014201520162017
$49MSeries C$35MSeries C$30MSeries D$37MSeries D
First round
Series C, $49M
Jun 2010
Biggest round
$49M
Series C · Jun 2010
Usual gap between rounds
19 months
the median of 3

The rounds

  1. May 2017
    Series D$37M1 new1 returning

    Reported by FinSMEsSEC filing: $35M sold, first sale Mar 2017

  2. Oct 2015
    Series D$30M

    No investor was named in the report.

    From a historical funding recordSEC filing: $15M sold, first sale Sept 2015

  3. Aug 2014
    Series C$35M2 new1 returning

    From a historical funding recordSEC filing: $30M sold, first sale Jul 2014

  4. Jun 2010
    Series C$49M1 new

    Reported by optinose.comSEC filing: $21M sold, first sale Jun 2010

Founders and team

From the SEC filings it signed: 4 on the team.

  • Ramy A. MahmoudChief Executive Officeri
  • Anthony J. KrickChief Accounting Officeri
  • Michael F. MarinoChief Legal Officer and Corporate Secretaryi
  • Paul A. SpenceChief Commercial Officeri

On the board, as filediCatherine E. OwenEric John BednarskiKyle John DempseyR. John FletcherSandra L. HeltonTomas J. HeymanWilhelmus John Groenhuysen

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2010Series C2014Series D2015Series D2017Entrepreneurs FundAvista Capital PartnersWFD VenturesFidelity Management/ Avista Capital

Everyone who backed them

Entrepreneurs FundVC firm2rounds
Avista Capital PartnersPrivate equity2rounds
WFD VenturesPrivate equity1round
Fidelity Management/ Avista Capitalno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists OptiNose as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Athyrium Capital ManagementPrivate equityPer its own site

Quick answers about OptiNose

Who invested in OptiNose?

OptiNose's investors include Entrepreneurs Fund, Avista Capital Partners, WFD Ventures and Fidelity Management/ Avista Capital.

How much has OptiNose raised?

OptiNose has raised $151M across 4 rounds since 2010.

When did OptiNose last raise?

OptiNose's most recent round was a Series D of $37M in May 2017.

What was OptiNose's biggest round?

OptiNose's largest round on record is $49M (Series C), in Jun 2010.

Who backed OptiNose first?

OptiNose's first round on record, in Jun 2010, was backed by Avista Capital Partners.

What stage is OptiNose at?

OptiNose's latest named round is a Series D, in May 2017.

Where is OptiNose based?

OptiNose is based in Norway.

Companies like OptiNose

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.